Pharma News
-
![Facing Omicron, Where is the Next]( "Facing Omicron, Where is the Next")
-
Facing Omicron, Where is the Next "Special Medicine"?
The COVID-19 outbreak started in early 2020 and has not completely disappeared. The new coronavirus is constantly mutating, among which Omicron has become the main epidemic strain in the world.
-
![Week 21 Partial Veterinary Drug Quotes 2]( "Week 21 Partial Veterinary Drug Quotes 2")
-
Week 21 Partial Veterinary Drug Quotes 2
Monosulfate kanamycin, the market inquiry is small, the transaction volume is small, the market price is 305, the actual transaction price is negotiable
-
![Analysis of The Veterinary Drug Raw Material Market in the 21st Week]( "Analysis of The Veterinary Drug Raw Material Market in the 21st Week")
-
Analysis of The Veterinary Drug Raw Material Market in the 21st Week
Florfenicol, the price has risen steadily, the market has returned to rationality, and the market quotation is above 455
-
![AstraZeneca's Selumetinib Capsules Received CDE Priority Review]( "AstraZeneca's Selumetinib Capsules Received CDE Priority Review")
-
AstraZeneca's Selumetinib Capsules Received CDE Priority Review
Today, the CDE official website announced that AstraZeneca's Selumetinib Capsules will be included in priority review. Selumetinib is the world's first drug approved for the treatment of neurofibromatosis type 1 plexiform neurofibromas (PN) in pediatric
-
![Pfizer to Sell All Drugs at Cost in Low-income Countries]( "Pfizer to Sell All Drugs at Cost in Low-income Countries")
-
Pfizer to Sell All Drugs at Cost in Low-income Countries
On May 25, Pfizer plans to sell all of its drug portfolio at cost in as many as 45 low-income countries. The program, which will initially launch in five African countries
-
![Reduced the Risk of Disease Progression by 71% Innovative Anti-cancer Therapy Reached Phase 3 Clinical Endpoint]( "Reduced the Risk of Disease Progression by 71% Innovative Anti-cancer Therapy Reached Phase 3 Clinical Endpoint")
-
Reduced the Risk of Disease Progression by 71% Innovative Anti-cancer Therapy Reached Phase 3 Clinical Endpoint
Today, SpringWorks Therapeutics announced that its oral specific gamma-secretase small molecule inhibitor nirogacestat met the primary endpoint in a Phase 3 clinical trial in patients with progressive disease (desmoid tumors)anti cancer therapy2022-05-25
-
![Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in China]( "Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in China")
-
Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in China
On May 23, Roche announced that its innovative drug crovalimab has achieved positive results in a phase III clinical study (COMMDORE 3) for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH)
-
![EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster]( "EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster")
-
EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster
On May 23, AstraZeneca said its new crown vaccine Vaxzevria had been approved by the European Medicines Agency (EMA) as a booster vaccine for adults.
-
![CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List]( "CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List")
-
CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List
On May 19, 2022, Beijing time, the World Health Organization released information on its official website, officially listing CanSino Bio’s recombinant covid-19 vaccine
-
![The First! Blockbuster Anti-inflammatory Drugs Gain New Indications]( "The First! Blockbuster Anti-inflammatory Drugs Gain New Indications")
-
The First! Blockbuster Anti-inflammatory Drugs Gain New Indications
On May 21, the U.S. FDA announced that it approved the expanded indication of Dupixent (dupilumab), a blockbuster IL-4/IL-13 inhibitor jointly developed by Sanofi and RegeneronAnti-inflammatory2022-05-23
-
![Sanofi's Innovative Cardiovascular Drug Dolivir Launched in China]( "Sanofi's Innovative Cardiovascular Drug Dolivir Launched in China")
-
Sanofi's Innovative Cardiovascular Drug Dolivir Launched in China
On May 22, 2022, Sanofi China announced that its innovative drug in the cardiovascular field, Dolivi® Clopidogrel Aspirin Tablets
Hot News
Extended Reading
-
![More than 20 chemical giants such as BASF, DSM, DuPont, Dow, and LANXESS have collectively raised prices!]()
More than 20 chemical giants such as BASF, DSM, DuPont, Dow, and LANXESS have collectively raised prices!
-
![Support standardization and promote healthy development of small food workshops]()
Support standardization and promote healthy development of small food workshops
-
![Sunscreen in Indonesia grows by more than 10% annually]()
Sunscreen in Indonesia grows by more than 10% annually
-
![US Import Prices Increase More Than Expected in October]()
US Import Prices Increase More Than Expected in October
-
![Who are the world’s top 10 cosmetic ingredients giants?]()
Who are the world’s top 10 cosmetic ingredients giants?
-
![From August 1st, many shipping companies charge high port congestion fees!]()
From August 1st, many shipping companies charge high port congestion fees!
-
![BASF announced that due to force majeure, this product has ceased supply!]()
BASF announced that due to force majeure, this product has ceased supply!
-
![Weekly Offers and Analyses for Chemicals (September 10, 2019)]()
Weekly Offers and Analyses for Chemicals (September 10, 2019)
-
![Dual Control' in a major chemical province! Raw materials skyrocket! The supply is in a hurry!]()
Dual Control' in a major chemical province! Raw materials skyrocket! The supply is in a hurry!
-
![Chemical Knowledge]()
Chemical Knowledge
-
![How to Make Potash: A DIY Guide for You To Try]()
How to Make Potash: A DIY Guide for You To Try
-
![ECHEMI Online Matching Meeting Accurately Match Supply and Demand Side]()
ECHEMI Online Matching Meeting Accurately Match Supply and Demand Side
